TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company
focused on developing and commercializing products targeted exclusively
for women, announced today that the Company will present at the JMP
Securities Healthcare Conference to be held July 9-10, 2013 at The St.
Regis New York.
Robert Finizio, Co-Founder and Chief Executive Officer, will present on
Tuesday, July 9, 2013 at 4:30 p.m. Eastern Daylight Time.
The presentation will also be available via a live audio webcast at the
following link: http://wsw.com/webcast/jmp21/TXMD.
Following the presentation, a replay will be available through
TherapeuticsMD’s website at www.therapeuticsmd.com
under the "Investor Relations" section and will remain available for 30
days after the presentation date.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a women’s health pharmaceutical company driven
to pursue the development and commercialization of advanced hormone
replacement therapies. We are currently developing advanced hormone
therapy pharmaceutical products designed to alleviate the symptoms of
and reduce the health risks resulting from menopause-related hormone
deficiencies. We are evaluating various other potential indications for
our hormone technology, including oral contraception, preterm birth,
vulvar and vaginal atrophy, and premature ovarian failure. More
information is available at www.therapeuticsmd.com.
TherapeuticsMD® is a registered trademark.
Copyright Business Wire 2013